DK162190A - Revers-transcriptase-inhibitorer til behandling af adenocarcinomaer - Google Patents

Revers-transcriptase-inhibitorer til behandling af adenocarcinomaer Download PDF

Info

Publication number: DK162190A
Authority: DK; Denmark
Prior art keywords: treatment; adenocarcinoma; transcriptase inhibitors; revers; revers transcriptase
Prior art date: 1988-01-07

Application number

DK162190A

Other languages

English (en)

Other versions

DK173766B1 (da

DK162190D0 (da

Inventor

Charles Anthony Hart

Kevin Mccarthy

Samuel John Leinster

Christopher Douglas Green

Ayad Mohamed Khala Al-Sumidaie

Original Assignee

Univ Liverpool

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-01-07

Filing date

1990-07-05

Publication date

1990-07-05

1990-07-05 Application filed by Univ Liverpool filed Critical Univ Liverpool

1990-07-05 Publication of DK162190A publication Critical patent/DK162190A/da

1990-07-05 Publication of DK162190D0 publication Critical patent/DK162190D0/da

2001-09-24 Application granted granted Critical

2001-09-24 Publication of DK173766B1 publication Critical patent/DK173766B1/da

Links

238000011282 treatment Methods 0.000 title abstract 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 title 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 title 1
208000009956 adenocarcinoma Diseases 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
206010006187 Breast cancer Diseases 0.000 abstract 1
208000026310 Breast neoplasm Diseases 0.000 abstract 1
201000009030 Carcinoma Diseases 0.000 abstract 1
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Natural products O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
239000003419 rna directed dna polymerase inhibitor Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Materials For Medical Uses (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

DK199001621A 1988-01-07 1990-07-05 Anvendelse af 3'-azido-3'-deoxythimidin til fremstilling af et medikament til behandling af brystscarcinoma hos mennesker DK173766B1 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB8800276		1988-01-07
GB888800276A GB8800276D0 (en)	1988-01-07	1988-01-07	Medical treatment
PCT/GB1989/000010 WO1989006132A1 (en)	1988-01-07	1989-01-06	Reverse transcriptase inhibitors for treating adenocarcinomas
GB8900010		1989-01-06

Publications (3)

Publication Number	Publication Date
DK162190A true DK162190A (da)	1990-07-05
DK162190D0 DK162190D0 (da)	1990-07-05
DK173766B1 DK173766B1 (da)	2001-09-24

Family

ID=10629601

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK199001621A DK173766B1 (da)	1988-01-07	1990-07-05	Anvendelse af 3'-azido-3'-deoxythimidin til fremstilling af et medikament til behandling af brystscarcinoma hos mennesker

Country Status (15)

Country	Link
US (1)	US5223490A (da)
EP (1)	EP0327200B1 (da)
JP (1)	JP2761420B2 (da)
KR (1)	KR900700110A (da)
CN (1)	CN1034134A (da)
AT (1)	ATE83378T1 (da)
AU (1)	AU626284B2 (da)
CA (1)	CA1331138C (da)
DE (1)	DE68903840T2 (da)
DK (1)	DK173766B1 (da)
GB (1)	GB8800276D0 (da)
IE (1)	IE63788B1 (da)
MY (1)	MY104462A (da)
WO (1)	WO1989006132A1 (da)
ZA (1)	ZA8993B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8823353D0 (en) *	1988-10-05	1988-11-09	Wellcome Found	Therapeutic nucleosides
FR2649982B1 (fr) *	1989-07-20	1991-09-27	Inst Nat Sante Rech Med	Membrane biologique artificielle
US5405837A (en) *	1993-05-18	1995-04-11	Indiana University Foundation	Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
US5576177A (en) *	1994-03-09	1996-11-19	St. Jude Children's Research Hospital	Bioassay for reverse transcriptase inhibitors
EP1174141A3 (en) *	1996-01-23	2003-04-23	ICN Pharmaceuticals, Inc.	Modulation of TH1/TH2 cytokine expression by ribavirin and ribavirin analogs in activated t-lymphocytes
DK0991415T3 (da) *	1997-12-22	2003-06-16	Schering Corp	Faste, oralt indgivelige dosisformer for ribavirin og fremgangsmåde til fremstilling af disse
US7351542B2 (en)	2002-05-20	2008-04-01	The Regents Of The University Of California	Methods of modulating tubulin deacetylase activity
WO2005090316A1 (en) *	2004-03-12	2005-09-29	Wyeth	HYDANTOINS HAVING RNase MODULATORY ACTIVITY
US7553967B2 (en) *	2004-03-12	2009-06-30	Wyeth	1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections
WO2005090299A2 (en) *	2004-03-12	2005-09-29	Wyeth	Carbamates as hiv anti-viral agents
WO2005090320A2 (en) *	2004-03-12	2005-09-29	Wyeth	Triazole derivatives and method of using the same to treat hiv infections
JP2009522281A (ja) *	2005-12-28	2009-06-11	トランスレーショナルセラピューティクス，インク．	翻訳機能障害に基づく治療法
US8497292B2 (en)	2005-12-28	2013-07-30	Translational Therapeutics, Inc.	Translational dysfunction based therapeutics
US7725227B2 (en) *	2006-12-15	2010-05-25	Gm Global Technology Operations, Inc.	Method, system, and apparatus for providing enhanced steering pull compensation
EP4216963A4 (en) *	2020-09-23	2024-10-23	Primefour Therapeutics, Inc.	Method for treating cancer with a reverse transcriptase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0199451B1 (en) *	1985-03-16	1996-03-06	The Wellcome Foundation Limited	Therapeutic nucleosides
GB8506869D0 (en) *	1985-03-16	1985-04-17	Wellcome Found	Antiviral compound
AU570853B2 (en) *	1985-08-26	1988-03-24	United States of America, as represented by the Secretary, U.S. Department of Commerce, The	Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
DD251984A5 (de) *	1985-09-17	1987-12-02	The Wellcome Foundation Limited,Gb	Verfahren zur herstellung von 3'-azidonucleosiden und pharmazeutisch vertraeglichen derivaten davon

1988
- 1988-01-07 GB GB888800276A patent/GB8800276D0/en active Pending
1989
- 1989-01-04 CA CA000587506A patent/CA1331138C/en not_active Expired - Fee Related
- 1989-01-04 MY MYPI89000008A patent/MY104462A/en unknown
- 1989-01-05 ZA ZA8993A patent/ZA8993B/xx unknown
- 1989-01-06 IE IE3689A patent/IE63788B1/en not_active IP Right Cessation
- 1989-01-06 AU AU29498/89A patent/AU626284B2/en not_active Ceased
- 1989-01-06 WO PCT/GB1989/000010 patent/WO1989006132A1/en not_active Ceased
- 1989-01-06 KR KR1019890701666A patent/KR900700110A/ko not_active Withdrawn
- 1989-01-06 US US07/536,669 patent/US5223490A/en not_active Expired - Lifetime
- 1989-01-06 DE DE8989300099T patent/DE68903840T2/de not_active Expired - Lifetime
- 1989-01-06 EP EP89300099A patent/EP0327200B1/en not_active Expired - Lifetime
- 1989-01-06 JP JP1501527A patent/JP2761420B2/ja not_active Expired - Lifetime
- 1989-01-06 AT AT89300099T patent/ATE83378T1/de active
- 1989-01-07 CN CN89100192A patent/CN1034134A/zh active Pending
1990
- 1990-07-05 DK DK199001621A patent/DK173766B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK173766B1 (da)	2001-09-24
IE890036L (en)	1989-07-07
MY104462A (en)	1994-04-30
ZA8993B (en)	1989-10-25
IE63788B1 (en)	1995-06-14
US5223490A (en)	1993-06-29
CN1034134A (zh)	1989-07-26
CA1331138C (en)	1994-08-02
WO1989006132A1 (en)	1989-07-13
GB8800276D0 (en)	1988-02-10
DK162190D0 (da)	1990-07-05
JP2761420B2 (ja)	1998-06-04
EP0327200B1 (en)	1992-12-16
AU626284B2 (en)	1992-07-30
ATE83378T1 (de)	1993-01-15
KR900700110A (ko)	1990-08-11
JPH03503049A (ja)	1991-07-11
DE68903840T2 (de)	1993-06-17
AU2949889A (en)	1989-08-01
EP0327200A1 (en)	1989-08-09
DE68903840D1 (de)	1993-01-28

Legal Events

Date	Code	Title
1997-06-16	PBP	Patent lapsed
2001-09-24	B1	Patent granted (law 1993)
2009-01-26	PUP	Patent expired

Publication	Publication Date	Title
DK162190A (da)	1990-07-05	Revers-transcriptase-inhibitorer til behandling af adenocarcinomaer
DK130387D0 (da)	1987-03-13	Transglutaminase inhibitorer
FI872720A7 (fi)	1987-12-21	Neutraaliset metalliendopeptidaasi-inhibiittorit hypertension hoidossa
DK177690D0 (da)	1990-07-26	Behandling af fedme
NO904622L (no)	1990-12-18	Aprotininanaloger og fremgangsmaate for fremstilling derav.
FI915152A7 (fi)	1992-05-02	HIV-käänteistranskriptaasi-inhibiittoreiden synergismi
IT8920364A0 (it)	1989-05-03	Trattamento della superficie di un tessuto duro.
NO894840D0 (no)	1989-12-04	Tilsetningsmiddel for broennbehandlingsfluider.
DK0530937T3 (da)	1999-05-10	Inhibitor med collagenfremkaldt blodpladeaggregering
NO157403C (no)	1988-03-23	Middel for behandling av saar.
DK161320C (da)	1991-12-09	Analogifremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thiophener
DE69007695D1 (de)	1994-05-05	Fucosidase-Inhibitoren.
ES2042726T3 (es)	1993-12-16	Beta-alquilmelatoninas.
DE68908344D1 (de)	1993-09-16	Oberflaechenbehandlung von metallen.
ATE134992T1 (de)	1996-03-15	Salze von n-nitrosophenylhydroxylamin
DE3462688D1 (en)	1987-04-23	1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
IT8967717A0 (it)	1989-08-24	Trattamento di superfici
IT1208370B (it)	1989-06-12	Dispositivo circuitale per determinare la presenza o la rimozione di oggetti particolarmente strumenti per trattamenti odontoiatrici
DK0458537T3 (da)	1999-10-18	Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ATE155686T1 (de)	1997-08-15	Hemmung von metastasen bei krebspatienten mit pyridyloxazol-2-onen
DK332786A (da)	1986-07-11	Anvendelse af 1,4-dihydropyridinderivater og kombinationer deraf med calcitoniner
FR2508909B1 (da)	1983-12-23
DK70283D0 (da)	1983-02-17	Kombination af tavle og tilhoerende skinner samt fremgangsmade til brug af samme
NO874017D0 (no)	1987-09-24	Verktoey for legging av gulvbord og parkett.
SE8701177L (sv)	1988-09-24	Arbetsmoebel med staellbart stativ